2026 International Fall Summit
October 28, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Use of Rucaparib (Rubraca®) and Indications
Use of Rucaparib (Rubraca®) and Indications
About this PQI
The purpose of this PQI is to discuss the various indications and management of rucaparib (Rubraca®).
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer
Last Updated: 05/15/2026
PQI: Implementing Reflex BRAF Testing in Metastatic Colorectal Cancer
Last Updated: 04/24/2026
PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management
Last Updated: 04/08/2026
PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma
Last Updated: 04/03/2026
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 05/19/2026
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 05/19/2026
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 05/19/2026
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 05/19/2026
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Pembrolizumab and Paclitaxel
Last Updated: 05/11/2026
Relacorilant and Albumin-Bound Paclitaxel
Last Updated: 04/28/2026
Avutometinib and Defactinib
Last Updated: 10/27/2025
Cisplatin and Etoposide
Last Updated: 10/25/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Pembrolizumab and Paclitaxel
Last Updated: 05/11/2026
Relacorilant and Albumin-Bound Paclitaxel
Last Updated: 04/28/2026
Bevacizumab, Carboplatin, and Paclitaxel
Last Updated: 04/06/2026
Irinotecan
Last Updated: 02/03/2026
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Pembrolizumab and Paclitaxel
Last Updated: 05/11/2026
Relacorilant and Albumin-Bound Paclitaxel
Last Updated: 04/28/2026
Avutometinib and Defactinib
Last Updated: 10/27/2025
Cisplatin and Etoposide
Last Updated: 10/25/2025
Patient Education Sheet
PQI in Action
Patient Education Sheet
Patient Education Sheet
Lutetium Lu-177 Vipivotide Tetraxetan
Last Updated: 02/23/2026
PQI in Action: Darolutamide (Nubeqa)
Last Updated: 01/22/2026
Talazoparib and Enzalutamide
Last Updated: 01/02/2026
Goserelin
Last Updated: 12/22/2025
Patient Education Sheet
PQI
PQI in Action
Rucaparib
Last Updated: 05/12/2026
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 09/06/2023
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 11/01/2019
Patient Education Sheet
PQI
PQI in Action
Rucaparib
Last Updated: 05/12/2026
PQI: PARP Inhibitor Eligibility in Ovarian Cancer
Last Updated: 09/06/2023
PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices
Last Updated: 11/01/2019
PQI
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer
Last Updated: 05/15/2026
Cyclophosphamide, Bortezomib, and Dexamethasone
Last Updated: 05/12/2026
Tacrolimus
Last Updated: 05/11/2026
Pembrolizumab and Paclitaxel
Last Updated: 05/11/2026